DISCONTINUATION of glucagon-like peptide-1 (GLP-1) receptor agonist treatment could reverse cardiovascular benefits, increasing the risk of heart disease in adults with Type 2 diabetes, a 2026 target trial emulation has found
By mimicking the natural hormone GLP-1, it helps regulate blood sugar levels and reduces appetite
These products have been sold directly to consumers for human use with dosing instructions, the FDAs statement to WIRED read
Cagrilintide is supplied as a lyophilized research peptide, intended strictly for laboratory research use only
J Allergy Clin Immunol 141(4):12391249 e4 Morishima Y, Ano S, Ishii Y et al (2013) Th17-associated cytokines as a therapeutic target for steroid-insensitive asthma[J]
of these, anagen is a growth stage and telogen is a resting phase